Literature DB >> 2647636

Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7.

D H Francis1, R A Moxley, C Y Andraos.   

Abstract

Gnotobiotic piglets inoculated with Escherichia coli serotype O157:H7 strains that produced Shiga-like toxin II developed brain lesions similar to those observed in edema disease of swine, including arteriolar necrosis and malacia. Loss of ability to produce Shiga-like toxin II resulted in loss of ability to cause brain lesions.

Entities:  

Mesh：

Year:  1989        PMID： 2647636      PMCID： PMC313274          DOI： 10.1128/iai.57.4.1339-1342.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  22 in total

1.  Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis.

Authors:  D H Francis; J E Collins; J R Duimstra
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets.

Authors:  S Tzipori; I K Wachsmuth; C Chapman; R Birden; J Brittingham; C Jackson; J Hogg
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

3.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

4.  Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine.

Authors:  K P Keenan; D D Sharpnack; H Collins; S B Formal; A D O'Brien
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

5.  Ultrastructure of the intestinal mucosa in pigs experimentally inoculated with an edema disease-producing strain of Escherichia coli (0139:K12:H1).

Authors:  S Methiyapun; J F Pohlenz; H U Bertschinger
Journal:  Vet Pathol       Date:  1984-09       Impact factor: 2.221

6.  Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP).

Authors:  D M Morrison; D L Tyrrell; L D Jewell
Journal:  Am J Clin Pathol       Date:  1986-07       Impact factor: 2.493

7.  Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs.

Authors:  H W Smith; P Green; Z Parsell
Journal:  J Gen Microbiol       Date:  1983-10

8.  Experimental infection of infant rabbits with verotoxin-producing Escherichia coli.

Authors:  C H Pai; J K Kelly; G L Meyers
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226
View more
  23 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.

Authors:  J E Samuel; L P Perera; S Ward; A D O'Brien; V Ginsburg; H C Krivan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Characterization of the NleF effector protein from attaching and effacing bacterial pathogens.

Authors:  Frank Echtenkamp; Wanyin Deng; Mark E Wickham; Alejandra Vazquez; Jose L Puente; Ajitha Thanabalasuriar; Samantha Gruenheid; B Brett Finlay; Philip R Hardwidge
Journal:  FEMS Microbiol Lett       Date:  2008-04       Impact factor: 2.742

6.  Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.

Authors:  M Ogawa; K Shimizu; K Nomoto; M Takahashi; M Watanuki; R Tanaka; T Tanaka; T Hamabata; S Yamasaki; Y Takeda
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

8.  Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs.

Authors:  Evelyn A Dean-Nystrom; Angela R Melton-Celsa; Joachim F L Pohlenz; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 9.  The piglet as a model for B cell and immune system development.

Authors:  J E Butler; K M Lager; I Splichal; D Francis; I Kacskovics; M Sinkora; N Wertz; J Sun; Y Zhao; W R Brown; R DeWald; S Dierks; S Muyldermans; J K Lunney; P B McCray; C S Rogers; M J Welsh; P Navarro; F Klobasa; F Habe; J Ramsoondar
Journal:  Vet Immunol Immunopathol       Date:  2008-11-01       Impact factor: 2.046

10.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.